|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 69.79 INR | +0.97% |
|
-1.02% | -12.91% |
| Market Cap | 1.09B 11.36M 9.93M 9.16M 8.42M 15.96M 16.23M 109M 42.92M 534M 42.66M 41.73M 1.84B | P/E 2024 |
-12.2x | P/E 2025 | -28.6x |
|---|---|---|---|---|---|
| Enterprise Value | 1.17B 12.14M 10.62M 9.79M 9M 17.06M 17.35M 117M 45.88M 571M 45.61M 44.61M 1.97B | EV / Sales 2024 |
3.16x | EV / Sales 2025 | 3.93x |
| Free-Float |
43.99% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.97% | ||
| 1 week | -1.02% | ||
| Current month | +1.35% | ||
| 1 month | +3.98% | ||
| 3 months | +0.30% | ||
| 6 months | +2.11% | ||
| Current year | -12.91% |
| 1 week | 67 |  | 72 |
| 1 month | 66.1 | | 79.69 |
| Current year | 36.3 | | 82.44 |
| 1 year | 36.3 | | 164.02 |
| 3 years | 36.3 | | 198.86 |
| 5 years | 36.3 | | 198.86 |
| 10 years | 13.85 | | 198.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Prashant Rathi
CEO | Chief Executive Officer | - | 01/06/2026 |
Atul Ranchal
PSD | President | 57 | 23/08/2023 |
D. S. Maity
CTO | Chief Tech/Sci/R&D Officer | 62 | 02/08/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 62 | 10/09/2010 | |
Lalit Mahajan
BRD | Director/Board Member | 60 | 13/09/2011 |
| Director/Board Member | 53 | 23/11/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.97% | -1.02% | -56.35% | -12.21% | 21.16M | |
| -0.07% | +0.59% | +14.64% | +80.97% | 48.66B | |
| +0.59% | -0.41% | +67.38% | +112.51% | 35.52B | |
| -0.59% | -0.82% | -3.14% | +38.43% | 12.07B | |
| -0.26% | -0.44% | +19.09% | +91.34% | 11.99B | |
| +1.32% | +1.15% | +32.83% | +126.50% | 9.29B | |
| -1.76% | -4.19% | +41.36% | -6.88% | 6.92B | |
| +0.33% | +0.42% | +19.54% | +38.03% | 7B | |
| -0.46% | +0.87% | +3.72% | +225.58% | 6.74B | |
| +6.39% | +7.36% | -16.52% | +20.63% | 6.36B | |
| Average | +0.65% | +1.15% | +12.26% | +71.49% | 14.46B | |
| Weighted average by Cap. | +0.33% | +1.20% | +27.28% | +86.73% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 795M 8.26M 7.22M 6.66M 6.12M 11.6M 11.8M 79.54M 31.21M 389M 31.02M 30.34M 1.34B | 826M 8.58M 7.5M 6.92M 6.36M 12.05M 12.26M 82.61M 32.41M 404M 32.22M 31.51M 1.39B |
| Net income | -196M -2.04M -1.78M -1.64M -1.51M -2.86M -2.91M -19.61M -7.69M -95.76M -7.65M -7.48M -330M | -99.67M -1.04M -906K -835K -768K -1.46M -1.48M -9.97M -3.91M -48.72M -3.89M -3.8M -168M |
| Net Debt | 55.16M 573K 501K 462K 425K 805K 819K 5.52M 2.17M 26.96M 2.15M 2.11M 92.93M | 75.39M 784K 685K 632K 581K 1.1M 1.12M 7.54M 2.96M 36.85M 2.94M 2.88M 127M |
Employees
323
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/07/26 | ₹69.79 | +0.97% | 6,581 |
| 15/07/26 | ₹69.12 | -0.25% | 20,479 |
| 14/07/26 | ₹69.29 | -0.80% | 16,504 |
| 13/07/26 | ₹69.85 | -0.84% | 46,916 |
| 10/07/26 | ₹70.44 | -0.10% | 59,356 |
- Stock Market
- Stocks
- BROOKS Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
